| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 05/04/2011 | CN101519651B Shigella flexneri phage strain and application thereof |
| 05/04/2011 | CN101044237B Method for preparing viral material |
| 05/03/2011 | US7935807 Chicken RNA polymerase I promoter and the use thereof |
| 05/03/2011 | CA2499430C Chicken astrovirus type 2 |
| 05/03/2011 | CA2454048C Therapeutic agents comprising pro-apoptotic proteins |
| 05/03/2011 | CA2378586C Replication-competent anti-cancer vectors |
| 05/03/2011 | CA2376600C Porcine circovirus recombinant poxvirus vaccine |
| 04/28/2011 | WO2011049835A1 Human parvovirus: humink parvovirus |
| 04/28/2011 | WO2011049263A1 Composition for inducing tissue regeneration by activating platelet-rich plasma (prp), and method for manufacturing same |
| 04/28/2011 | WO2011048560A1 Improved reverse genetics methods for virus rescue |
| 04/28/2011 | WO2011048353A2 Construct |
| 04/28/2011 | WO2011048215A1 Detection of a circovirus in calves suffering from bovine neonatal pancytopenia |
| 04/28/2011 | WO2010138885A3 Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses |
| 04/28/2011 | US20110099646 Green fluorescent protein optimized for expression with self-cleaving polypeptides |
| 04/28/2011 | US20110098338 RNA Interference for the Treatment of Heart Failure |
| 04/28/2011 | US20110097785 Method of replicating viruses in suspension cultures of dog kidney cells |
| 04/28/2011 | US20110097556 Biological control of nanoparticle nucleation, shape and crystal phase |
| 04/28/2011 | US20110097353 Poultry viral materials and methods related thereto |
| 04/28/2011 | DE102009044224A1 Methode zur Produktion von HCV Virus-ähnlichen Partikeln Method for the production of HCV virus-like particles |
| 04/28/2011 | CA2778533A1 Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof |
| 04/28/2011 | CA2778351A1 Composition for inducing tissue regeneration by activating platelet-rich plasma (prp), and method for manufacturing same |
| 04/28/2011 | CA2778332A1 Improved reverse genetics methods for virus rescue |
| 04/28/2011 | CA2777159A1 Detection of a circovirus in calves suffering from bovine neonatal pancytopenia |
| 04/27/2011 | EP2314721A1 Porcine reproductive and respiratory syndrome isolates and methods of use |
| 04/27/2011 | EP1578959B1 Immunizing fish against viral infection |
| 04/27/2011 | CN1910275B Compositions comprising fetal liver cells and methods useful for HCV infection |
| 04/27/2011 | CN102031246A Preparation containing recombinant adenoviruses |
| 04/27/2011 | CN101306198B NR2B recombinant adenovirus vaccine |
| 04/26/2011 | US7932371 Tick octopamine receptor nucleic acid molecules |
| 04/26/2011 | US7932355 Virally-safe factor VIII with a low content of higher multimers |
| 04/26/2011 | US7932350 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 04/26/2011 | US7932074 Multivalent human-bovine rotavirus vaccine |
| 04/26/2011 | US7932066 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 04/26/2011 | US7932056 Crustaceans as production systems for therapeutic proteins |
| 04/26/2011 | US7931893 A pseudotyped feline immunodeficiency virus virion; transfection; expression vectors packaged in packaging cells to generate high titer recombinant virus stocks; gene therapy |
| 04/26/2011 | CA2271234C Animal models of human prostate cancer progression |
| 04/21/2011 | WO2011047158A1 Isolation of a virus related to canine parvovirus-2 from a raccoon |
| 04/21/2011 | WO2011046996A2 Consensus sequence for influenza a virus |
| 04/21/2011 | WO2011045772A1 In vitro method for obtaining intrahepatic fibroblasts infected with hepatitis c virus |
| 04/21/2011 | WO2011045381A1 Process for adenovirus purification from high cell density cultures |
| 04/21/2011 | WO2011045378A1 Method for the purification of adenovirus particles |
| 04/21/2011 | WO2010134975A3 Methods for enhancing infectivity of retroviruses |
| 04/21/2011 | US20110093962 Breast disease targets and uses thereof |
| 04/21/2011 | US20110092687 Stable lysis buffer mixture for extracting nucleic acids |
| 04/21/2011 | US20110092680 Method of separating and purifying cellular components using non-covalent bond between cucurbital derivative and guest compound and apparatus using the same |
| 04/21/2011 | US20110092391 Phage lambda display constructs |
| 04/21/2011 | US20110091881 Mycobacterial genes down-regulated during latency |
| 04/21/2011 | US20110091500 Inactivated Live-Attenuated Bluetongue Virus Vaccine |
| 04/21/2011 | CA2777692A1 Isolation of a virus related to canine parvovirus-2 from a raccoon |
| 04/21/2011 | CA2777116A1 Process for adenovirus purification from high cell density cultures |
| 04/21/2011 | CA2776461A1 Method for the purification of adenovirus particles |
| 04/21/2011 | CA2775277A1 Infectious clones of torque teno virus |
| 04/20/2011 | EP2311951A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 04/20/2011 | EP2311950A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 04/20/2011 | EP2311853A1 Infectious cDNA of an approved vaccine strain of measles virus. Use for immunogenic compositions |
| 04/20/2011 | EP2310495A1 Compositions and methods for the production of alpha-herpesviruses |
| 04/20/2011 | EP2310494A1 Cell line for propagation of highly attenuated alphaviruses |
| 04/20/2011 | EP2310048A1 Stabilizer and vaccine composition comprising one or more live attenuated flaviviruses |
| 04/20/2011 | CN102027107A Reducing conjugative plasmids in bacteria |
| 04/20/2011 | CN102021149A Gene NSI deficit type respiratory syncytial virus and application thereof to treating lung cancer |
| 04/20/2011 | CN102021148A Gene NS1 (Structural Protein) defective respiratory syncytial virus and application thereof |
| 04/20/2011 | CN102021147A A novel human virus causing severe acute respiratory syndrome (sars) and uses thereof |
| 04/20/2011 | CN102018957A Production method of hog cholera live vaccine |
| 04/20/2011 | CN102018956A F-gene type attenuated live mumps vaccine and preparation method and application thereof |
| 04/20/2011 | CN101372686B Infected protein mediated method for producing recombinant baculovirus particle |
| 04/19/2011 | US7927601 Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof |
| 04/19/2011 | US7927585 Production of recombinant AAV virions |
| 04/19/2011 | CA2478081C Multiple and multivalent dna vaccines in ovo |
| 04/19/2011 | CA2282790C Chimeric flavivirus vaccines |
| 04/19/2011 | CA2226301C Natural or synthetic retroelement sequence enabling nucleotide sequence insertion into a eukaryotic cell |
| 04/19/2011 | CA2185859C Preparation of virally inactivated intravenously injectable immune serum globulin |
| 04/14/2011 | WO2011044561A1 Attenuated influenza viruses and vaccines |
| 04/14/2011 | WO2011042551A1 Method of generating hcv-derived virus-like particles |
| 04/14/2011 | WO2011042029A1 A method and composition for creating conditional lethality for virus mutants and for eliminating the viability of an eukaryotic cell |
| 04/14/2011 | US20110086415 Electrospun Fiber Pre-Concentrator |
| 04/14/2011 | US20110086411 Method of Producing a Polypeptide or Virus of Interest in a Continuous Cell Culture |
| 04/14/2011 | US20110086338 Bacteriophage/Quantum-Dot (Phage-QD) Nanocomplex to Detect Biological Targets in Clinical and Environmental Isolates |
| 04/14/2011 | US20110086063 Vaccines for prevention and treatment of addiction |
| 04/14/2011 | US20110086006 HCV NS3-NS4 Protease Resistance Mutants |
| 04/13/2011 | EP2307549A1 Influenza virus-like particles (vlps) comprising hemagglutinin |
| 04/13/2011 | EP1334200B1 Multiple inducible gene regulation system |
| 04/13/2011 | CN1539022B Viral drug susceptibility test |
| 04/13/2011 | CN1379820B Lentiviral vectors for preparation of immunotherapeutical compositions |
| 04/13/2011 | CN102016026A Nucleic acid containing chimeric gene derived from hepatitis type-C virus |
| 04/13/2011 | CN102016011A Simian adenoviruses SADV-36,-42.1, -42.2, and -44 and uses thereof |
| 04/13/2011 | CN102014952A Vaccine compositions for the treatment of dengue fever and uses thereof |
| 04/13/2011 | CN101633908B Method for laodelphax striatellus to obtain rice black-streaked dwarf virus (RBSDV) from refrigerated diseased leaves |
| 04/13/2011 | CN101423836B Porcine circovirus I type infectious clone and virus rescued thereby and application thereof |
| 04/12/2011 | US7923534 Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3 |
| 04/12/2011 | US7923017 Modified Vaccinia Ankara virus variant |
| 04/12/2011 | CA2626498C Recombinant chimeric virus |
| 04/12/2011 | CA2543846C Hcv replicons containing ns5b from genotype 2b |
| 04/12/2011 | CA2326719C Use of triplex structure dna sequences for transferring nucleotide sequences |
| 04/07/2011 | WO2011040535A1 Hepatitis c virus vaccine composition |
| 04/07/2011 | WO2011040527A1 TRANSGENIC BIRD CAPABLE OF EXPRESSING α-GALACTOSE EPITOPE, VIRUS, AND VACCINE |
| 04/07/2011 | WO2011040526A1 VIRUS CAPABLE OF EXPRESSING α-GALACTOSE EPITOPE, AND METHOD FOR PRODUCTION OF VACCINE |
| 04/07/2011 | WO2011039646A2 Papilloma virus -like particles for targeted gene delivery |
| 04/07/2011 | WO2011039639A2 Jfh-1 based hcv cell culture systems for ns5a of genotypes 1-7 |
| 04/07/2011 | WO2011039612A1 Detection and use of antiviral resistance mutations |
| 04/07/2011 | WO2011038737A1 Infectious hepatitis c viruses of genotype 3a and 4a and uses thereof |